Graphislactone A is the major analogue of a family of phenolic benzopyranones isolated from a mycobiont of lichens of the genus Graphis, first reported by Japanese researchers at Kobe Pharmaceutical University in 1997. Graphislactone A protects against oxidative injury by dose-dependent free radical scavenging and antioxidant activity.